“The anti-snoring treatments market is poised to reach USD 1,232.6 million by 2020 from USD 744.7 million in 2015, growing at a CAGR of 10.6% from 2015 to 2020. This market is categorized on the basis of device type, surgical procedure, and region. The anti-snoring devices market is expected to grow at the highest CAGR in the coming five years.
Major factors contributing to the growth of the global anti-snoring treatments market include the growing awareness on the ill effects of snoring. Key players and other stakeholders in this market are taking initiatives to create awareness on the problems of snoring. For instance, the British Snoring and Sleep Apnoea Association (BSSAA) organize the National Stop Snoring Week every year. In 2015, the BSSAA organized this activity from 20th April to 25th April. The aim of this event is to create awareness among people about the consequences of snoring and sleep apnea, and the available treatments for these disorders. In 2014, SleepPath (U.S.), a company providing anti-snoring t-shirts for people suffering from positional snoring, released a video named Snoring Your Best Pick Up Lines. This is a humorous video created to spread public awareness regarding snoring. Other factors responsible for the growth of this market include the growing geriatric and obese population, presence of a large number of cigarette smokers and alcoholics, and a large pool of untapped snoring population.
North America and Europe are the fastest-growing markets. High growth in these markets is attributed to the growing awareness on the ill effects of snoring, presence of a large number of market players, and presence of a large pool of untreated snoring population..
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the anti-snoring treatments market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Information on the product portfolios of the key players in the anti-snoring treatments market. The report analyzes this market by device type, surgical procedure, and region
• Product Development/Innovation: Insights on R&D activities, and new product launches in the anti-snoring treatments market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of some of the key players in the anti-snoring treatments market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various anti-snoring products across regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the anti-snoring treatments market
”
“TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKET SEGMENTATION 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 MARKET STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN & DATA TRIANGULATION 22
2.3 KEY DATA FROM SECONDARY SOURCES 23
2.4 KEY DATA FROM PRIMARY SOURCES 23
2.5 KEY INDUSTRY INSIGHTS 24
2.6 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 30
4.1 ANTI-SNORING DEVICES MARKET, BY TYPE 30
4.2 ANTI-SNORING SURGICAL PROCEDURES MARKET, BY TYPE 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.2 MARKET SEGMENTATION 35
5.2.1 BY DEVICE TYPE 35
5.2.2 BY SURGICAL PROCEDURE TYPE 35
5.2.3 BY REGION 36
5.3 MARKET DYNAMICS 36
5.3.1 DRIVERS 37
5.3.1.1 Rising awareness in developed countries about the ill effects of snoring and benefits of associated treatments 37
5.3.1.2 Rising geriatric and obese population 38
5.3.1.3 Growing cigarette and alcohol consumption 38
5.3.1.4 Technological advancements in anti-snoring devices 39
5.3.2 RESTRAINTS/LIMITATIONS 40
5.3.2.1 Poor efficacy and lack of scientific validation of the anti-snoring devices currently available in the market 40
5.3.2.2 High cost of custom-made oral appliances 40
5.3.2.3 Social stigma associated with snoring 40
5.3.3 OPPORTUNITIES 41
5.3.3.1 Presence of a large untreated population 41
5.3.3.2 Developing countries to offer high growth opportunities 41
6 ANTI-SNORING DEVICES MARKET, BY TYPE 43
6.1 INTRODUCTION 44
6.1.1 ORAL APPLIANCES/MOUTHPIECES 46
6.1.1.1 Mandibular advancement devices (MADs) 49
6.1.1.1.1 Non-custom MADs 52
6.1.1.1.2 Custom-made MADs 53
6.1.1.2 Tongue-retaining devices (TRDs) 55
6.1.2 NASAL DEVICES 57
6.1.2.1 External nasal dilators (nasal strips) 58
6.1.2.2 Other nasal devices (nasal stents, nasal clips, and septal stimulators) 60
6.1.3 POSITION CONTROL DEVICES 62
6.1.4 CHIN STRAPS 64
6.1.5 TONGUE-STABILIZING DEVICES (TSDS) 65
6.1.6 EPAP THERAPY DEVICES 67
7 ANTI-SNORING SURGICAL PROCEDURES MARKET, BY TYPE 69
7.1 INTRODUCTION 70
7.2 UVULOPALATOPHARYNGOPLASTY (UPPP) 73
7.3 LASER-ASSISTED UVULOPALATOPLASTY (LAUP) 73
7.4 RADIOFREQUENCY ABLATION (SOMNOPLASTY) 74
7.5 PILLAR PROCEDURE 75
7.6 INJECTION SNOREPLASTY/SCLEROTHERAPY 76
7.7 PALATAL STIFFENING PROCEDURES 76
7.8 OTHER ANTI-SNORING SURGICAL PROCEDURES 77
8 REGIONAL ANALYSIS 79
8.1 INTRODUCTION 80
8.2 NORTH AMERICA 82
8.2.1 U.S. 86
8.2.2 CANADA 89
8.3 EUROPE 91
8.3.1 GERMANY 95
8.3.2 U.K. 97
8.3.3 FRANCE 99
8.3.4 REST OF EUROPE (ROE) 101
8.4 ASIA 104
8.5 ROW 108
9 COMPETITIVE LANDSCAPE 112
9.1 OVERVIEW 112
9.1.1 NEW PRODUCT LAUNCHES 113
9.1.2 ACQUISITIONS 114
9.1.3 OTHER GROWTH STRATEGIES 114
10 COMPANY PROFILES 115
10.1 INTRODUCTION 115
10.2 SLEEPING WELL, LLC 116
10.3 APNEA SCIENCES CORPORATION 117
10.4 THE PURE SLEEP COMPANY 118
10.5 SOMNOMED LIMITED 119
10.6 AIRWAY MANAGEMENT INC. 121
10.7 THERAVENT, INC. 122
10.8 TOMED DR. TOUSSAINT GMBH 123
10.9 GLAXOSMITHKLINE, PLC 124
10.10 MEDITAS LTD. 126
10.11 INNOVATIVE HEALTH TECHNOLOGIES (NZ) LIMITED 127
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
11 APPENDIX 128
11.1 INSIGHTS FROM INDUSTRY EXPERTS 128
11.2 DISCUSSION GUIDE 129
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 131
11.4 AVAILABLE CUSTOMIZATIONS 131
11.5 RELATED REPORTS 132
“
“LIST OF TABLES
TABLE 1 GROWING AWARENESS ABOUT SNORING AND RELATED CONDITIONS TO DRIVE THE MARKET GROWTH 39
TABLE 2 POOR EFFICACY AND LACK OF SCIENTIFIC VALIDATION OF ANTI-SNORING DEVICES IS A MAJOR MARKET RESTRAINT 40
TABLE 3 PRESENCE OF LARGE UNTREATED POPULATION OFFERS HIGH GROWTH OPPORTUNITIES FOR THE ANTI-SNORING TREATMENTS MARKET 42
TABLE 4 ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 45
TABLE 5 ANTI-SNORING DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 45
TABLE 6 NORTH AMERICA: ANTI-SNORING DEVICES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 46
TABLE 7 EUROPE: ANTI-SNORING DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 46
TABLE 8 COMPARISON OF KEY ANTI-SNORING ORAL APPLIANCES AVAILABLE IN THE MARKET 47
TABLE 9 ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 48
TABLE 10 ORAL APPLIANCES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 48
TABLE 11 NORTH AMERICA: ORAL APPLIANCES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 48
TABLE 12 EUROPE: ORAL APPLIANCES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 49
TABLE 13 MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013–2020 (USD MILLION) 50
TABLE 14 MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 50
TABLE 15 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 51
TABLE 16 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 51
TABLE 17 NON-CUSTOM MADS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 52
TABLE 18 NORTH AMERICA: NON-CUSTOM MADS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 53
TABLE 19 EUROPE: NON-CUSTOM MADS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 53
TABLE 20 CUSTOM-MADE MADS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 54
TABLE 21 NORTH AMERICA: CUSTOM-MADE MADS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 54
TABLE 22 EUROPE: CUSTOM-MADE MADS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 55
TABLE 23 TONGUE-RETAINING DEVICES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 55
TABLE 24 NORTH AMERICA: TONGUE-RETAINING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 56
TABLE 25 EUROPE: TONGUE-RETAINING DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD THOUSAND) 56
TABLE 26 NASAL DEVICES MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 57
TABLE 27 NASAL DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 57
TABLE 28 NORTH AMERICA: NASAL DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 58
TABLE 29 EUROPE: NASAL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 58
TABLE 30 EXTERNAL NASAL DILATORS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 59
TABLE 31 NORTH AMERICA: EXTERNAL NASAL DILATORS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 59
TABLE 32 EUROPE: EXTERNAL NASAL DILATORS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 60
TABLE 33 OTHER NASAL DEVICES 60
TABLE 34 OTHER NASAL DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 61
TABLE 35 NORTH AMERICA: OTHER NASAL DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 61
TABLE 36 EUROPE: OTHER NASAL DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 62
TABLE 37 POSITION CONTROL DEVICES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 62
TABLE 38 NORTH AMERICA: POSITION CONTROL DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 63
TABLE 39 EUROPE: POSITION CONTROL DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 63
TABLE 40 CHIN STRAPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 64
TABLE 41 NORTH AMERICA: CHIN STRAPS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 64
TABLE 42 EUROPE: CHIN STRAPS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 65
TABLE 43 TONGUE-STABILIZING DEVICE (TSD): AVEOTSD 65
TABLE 44 TONGUE STABILIZING DEVICES MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 66
TABLE 45 NORTH AMERICA: TONGUE STABILIZING DEVICES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 66
TABLE 46 EUROPE: TONGUE STABILIZING DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 66
TABLE 47 EPAP THERAPY DEVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 67
TABLE 48 NORTH AMERICA: EPAP THERAPY DEVICES MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 68
TABLE 49 ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 71
TABLE 50 ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 71
TABLE 51 NORTH AMERICA: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE,
BY COUNTRY, 2013-2020 (USD MILLION) 72
TABLE 52 EUROPE: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 72
TABLE 53 UVULOPALATOPHARYNGOPLASTY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 73
TABLE 54 LASER-ASSISTED UVULOPALATOPLASTY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 74
TABLE 55 RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 74
TABLE 56 PILLAR PROCEDURE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 57 INJECTION SNOREPLASTY MARKET SIZE, BY REGION,
2013-2020 (USD THOUSAND) 76
TABLE 58 PALATAL STIFFENING PROCEDURES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 77
TABLE 59 OTHER SURGICAL PROCEDURES MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 78
TABLE 60 ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 80
TABLE 61 ANTI-SNORING TREATMENTS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 80
TABLE 62 NORTH AMERICA: ANTI-SNORING TREATMENTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 81
TABLE 63 EUROPE: ANTI-SNORING TREATMENTS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 81
TABLE 64 NORTH AMERICA: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 84
TABLE 65 NORTH AMERICA: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 84
TABLE 66 NORTH AMERICA: ORAL APPLIANCES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 85
TABLE 67 NORTH AMERICA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE,
BY TYPE, 2013-2020 (USD MILLION) 85
TABLE 68 NORTH AMERICA: NASAL DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 85
TABLE 69 NORTH AMERICA: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 86
TABLE 70 U.S.: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 87
TABLE 71 U.S.: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 88
TABLE 72 U.S.: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 88
TABLE 73 U.S.: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 88
TABLE 74 CANADA: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 89
TABLE 75 CANADA: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 90
TABLE 76 CANADA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 90
TABLE 77 CANADA: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 90
TABLE 78 EUROPE: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 93
TABLE 79 EUROPE: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 93
TABLE 80 EUROPE: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 93
TABLE 81 EUROPE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 94
TABLE 82 EUROPE: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 94
TABLE 83 EUROPE: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 95
TABLE 84 GERMANY: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 96
TABLE 85 GERMANY: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 96
TABLE 86 GERMANY: MANDIBULAR ADVANCEMENT DEVICES (MADS) MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 96
TABLE 87 GERMANY: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 97
TABLE 88 U.K.: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 98
TABLE 89 U.K.: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD THOUSAND) 98
TABLE 90 U.K.: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 99
TABLE 91 U.K.: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 99
TABLE 92 FRANCE: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 100
TABLE 93 FRANCE: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 100
TABLE 94 FRANCE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 100
TABLE 95 FRANCE: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 101
TABLE 96 ROE: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 102
TABLE 97 ROE: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD THOUSAND) 102
TABLE 98 ROE: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 102
TABLE 99 ROE: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 103
TABLE 100 ASIA: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 105
TABLE 101 ASIA: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 106
TABLE 102 ASIA: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 106
TABLE 103 ASIA: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 106
TABLE 104 ASIA: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 107
TABLE 105 ASIA: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 107
TABLE 106 ROW: ANTI-SNORING TREATMENTS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 109
TABLE 107 ROW: ANTI-SNORING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 109
TABLE 108 ROW: ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 109 ROW: MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 110
TABLE 110 ROW: NASAL DEVICES MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 111 ROW: ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 111
TABLE 112 NEW PRODUCT LAUNCHES, 2012–2015 113
TABLE 113 ACQUISITIONS, 2012–2015 114
TABLE 114 OTHER GROWTH STRATEGIES, 2012–2015 114
TABLE 115 COMPARISON OF KEY ANTI-SNORING ORAL APPLIANCES AVAILABLE IN THE MARKET 115
TABLE 116 EXCHANGE RATES (UTILIZED FOR CONVERSION OF GBP TO USD) 124
“
“LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 ANTI-SNORING DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 19
FIGURE 3 ANTI-SNORING SURGICAL PROCEDURES MARKET SIZE ESTIMATION:
BOTTOM-UP APPROACH 20
FIGURE 4 COUNTRY-LEVEL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 21
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY TYPE OF TREATMENT, DESIGNATION, AND REGION 21
FIGURE 6 DATA TRIANGULATION METHODOLOGY 22
FIGURE 7 ANTI-SNORING TREATMENTS MARKET SNAPSHOT, 2015 VS. 2020 25
FIGURE 8 ORAL APPLIANCES IS THE FASTEST-GROWING DEVICE SEGMENT 26
FIGURE 9 NASAL DEVICES IS THE SECOND LARGEST SEGMENT IN THE DEVICES MARKET AND IT IS DOMINATED BY EXTERNAL NASAL DILATORS (NASAL STRIPS) 27
FIGURE 10 IN 2015, UPPP TO COMMAND THE LARGEST SHARE OF THE SURGICAL PROCEDURES MARKET 28
FIGURE 11 NORTH AMERICA IS EXPECTED TO COMMAND THE LARGEST SHARE IN 2015, AND GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 29
FIGURE 12 ORAL APPLIANCES SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 30
FIGURE 13 MADS SEGMENT TO PROVIDE HIGH-GROWTH OPPORTUNITIES IN THE
FORECAST PERIOD 31
FIGURE 14 ORAL APPLIANCES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE ANTI-SNORING DEVICES MARKET IN 2015 31
FIGURE 15 THE U.S. TO WITNESS HIGHEST GROWTH BETWEEN 2015 & 2020 32
FIGURE 16 UPPP, LAUP, AND RFA ARE EXPECTED TO BE THE MAJOR SEGMENTS IN THE SURGICAL PROCEDURES MARKET BETWEEN 2015 TO 2020 33
FIGURE 17 ANTI-SNORING TREATMENTS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 37
FIGURE 18 ANTI-SNORING DEVICES MARKET: ORAL APPLIANCES ARE EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 44
FIGURE 19 MADS ARE EXPECTED TO COMMAND THE LARGEST SHARE IN THE ORAL APPLIANCES SEGMENT IN 2015 47
FIGURE 20 NON-CUSTOM MADS ARE SLATED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 49
FIGURE 21 RADIOFREQUENCY ABLATION PROCEDURES MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 70
FIGURE 22 NORTH AMERICAN ANTI-SNORING TREATMENTS MARKET SNAPSHOT 83
FIGURE 23 EUROPEAN ANTI-SNORING TREATMENTS MARKET SNAPSHOT 92
FIGURE 24 ASIA: ANTI-SNORING DEVICES MARKET SNAPSHOT 104
FIGURE 25 ROW: ANTI-SNORING DEVICES MARKET SNAPSHOT 108
FIGURE 26 KEY PLAYERS ADOPTED INORGANIC AS WELL AS ORGANIC GROWTH STRATEGIES BETWEEN 2012 & 2015 112
FIGURE 27 NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY ADOPTED BY PLAYERS BETWEEN 2012 AND 2015 113
FIGURE 28 SOMNOMED LIMITED: COMPANY SNAPSHOT 119
FIGURE 29 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT 124
“
